Literature DB >> 20715158

Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients.

Xiao-Yong Huang1, Ai-Wu Ke, Guo-Ming Shi, Zhen-Bin Ding, Ranjan Prasad Devbhandari, Fang-Ming Gu, Quan-Lin Li, Zhi Dai, Jian Zhou, Jia Fan.   

Abstract

BACKGROUND: Previous studies have indicated that CD151, a hydrophobic protein, forms a functional complex with the proto-oncogene that encodes an N-methyl-N'-nitro-N-nitroso-guanidine (MET) protein (c-Met), and CD151 overexpression reportedly is involved in metastasis/invasion of several tumors. The objective of the current study was to investigate the expression and role of CD151 and/or c-Met in intrahepatic cholangiocarcinoma (ICC).
METHODS: Sixty ICC tissues with matched nontumorous tissues and 20 normal liver tissues were used to analyze CD151 expression at the level of messenger RNA (mRNA) and protein. Then, the expression of CD151 in an ICC cell line was interrupted using a specific lentiviral-mediated small hairpin RNA (shRNA)-CD151, and the role of CD151 in the proliferation, metastasis, and invasion of ICC cells was assessed. The expression of CD151/c-Met was examined further by immunohistochemistry in a tissue microarray (TMA) that included 140 samples of ICC, and the prognostic role of CD151 and/or c-Met in ICC was evaluated in Kaplan-Meier and Cox regression analyses.
RESULTS: The expression of CD151 in ICC tissues was much higher than that in nontumorous samples and normal liver; and, after the down-regulation of CD151, HCCC-9810 cells had decreased capability for metastasis/invasion in vitro. CD151 overexpression was correlated significantly with larger tumors, poor differentiation, multiple nodular, microvascular/bile duct invasion, and lymphatic metastasis (P<.05). The postoperative 2-year and 5-year overall survival (OS) rates for patients with low CD151 expression (<50% tumor staining) and/or low c-Met expression (<20% tumor staining) were higher than the rates for patients with high CD151 expression (≥50% tumor staining) and/or high c-Met expression (≥20% tumor staining). Multivariate analysis revealed that CD151 overexpression and c-Met overexpression were independent prognostic markers for ICC.
CONCLUSIONS: Overexpression of CD151 was implicated in metastasis/invasion of ICC, and both CD151 overexpression and c-Met overexpression may be potential molecular therapeutic targets for ICC.
Copyright © 2010 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20715158     DOI: 10.1002/cncr.25485

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  21 in total

Review 1.  Molecular diagnosis of intrahepatic cholangiocarcinoma.

Authors:  Hiroaki Haga; Tushar Patel
Journal:  J Hepatobiliary Pancreat Sci       Date:  2014-09-29       Impact factor: 7.027

2.  Tetraspanin CD151 expression associated with prognosis for patients with advanced gastric cancer.

Authors:  Byung Woog Kang; Dakeun Lee; Ho Young Chung; Jae Ho Han; Young-Bae Kim
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-05       Impact factor: 4.553

3.  Overexpressions of CK2β and XIAP are associated with poor prognosis of patients with cholangiocarcinoma.

Authors:  Fan Zhou; Jiewei Xu; Guoping Ding; Liping Cao
Journal:  Pathol Oncol Res       Date:  2013-07-05       Impact factor: 3.201

Review 4.  Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies.

Authors:  S Detchokul; E D Williams; M W Parker; A G Frauman
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

5.  Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy?

Authors:  H J Park; K Kim; J H Paik; E K Chie; S Kim; J-Y Jang; S W Kim; S-W Han; D-Y Oh; S-A Im; T-Y Kim; Y-J Bang; S W Ha
Journal:  Clin Transl Oncol       Date:  2015-10-12       Impact factor: 3.405

6.  A high level of TM4SF5 is associated with human esophageal cancer progression and poor patient survival.

Authors:  Yong-bing Wu; You-sheng Huang; Ya-ping Xu; Yu-fang Sun; Dong-liang Yu; Xiao-qiang Zhang; Xiang Long; Shu-qiang Zhu; Jiang-liang Zhou; Jian-jun Xu
Journal:  Dig Dis Sci       Date:  2013-04-30       Impact factor: 3.199

7.  A high level of integrin α6 expression in human intrahepatic cholangiocarcinoma cells is associated with a migratory and invasive phenotype.

Authors:  Yan-bing Ding; Bin Deng; You-sheng Huang; Wei-ming Xiao; Jian Wu; Yan-qing Zhang; Yuan-zhi Wang; Da-cheng Wu; Guo-tao Lu; Ke-yan Wu
Journal:  Dig Dis Sci       Date:  2013-01-11       Impact factor: 3.199

Review 8.  CD151 in cancer progression and metastasis: a complex scenario.

Authors:  Rafal Sadej; Alicja Grudowska; Lukasz Turczyk; Radzislaw Kordek; Hanna M Romanska
Journal:  Lab Invest       Date:  2013-11-18       Impact factor: 5.662

9.  High level of CD73 predicts poor prognosis of intrahepatic cholangiocarcinoma.

Authors:  Ya-Ping Xu; Ying-Qun Zhou; Yu-Jie Zhao; Yan Zhao; Feng Wang; Xiao-Yong Huang; Chuan-Yong Guo
Journal:  J Cancer       Date:  2021-06-04       Impact factor: 4.207

10.  Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma.

Authors:  Chi Zhang; Dou-Sheng Bai; Xiao-Yong Huang; Guo-Ming Shi; Ai-Wu Ke; Liu-Xiao Yang; Xin-Rong Yang; Jian Zhou; Jia Fan
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.